Bicalutamide Market Analysis By Type (Tablets, Injectable Formulations, Capsule), By Application (Single Drug For Prostate Cancer, Combined Chemotherapy For Prostate Cancer), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), by End User (Hospitals & Clinics, Ambulatory Surgical Centers, Specialty Clinics) and by Region: Global Forecast, 2024 - 2034
- PUBLISHED ON
- 2024-04-29
- NO OF PAGES
- 221
- CATEGORY
- Healthcare & Life Sciences
Market Overview
The Bicalutamide market is predicted to develop at a compound annual growth rate (CAGR) of 8.11% from 2024 to 2034, when it is projected to reach USD 4.52 Billion, based on an average growth pattern. The market is estimated to reach a value of USD 1.92 Billion in 2024.
SOURCE: We Market Research
Belicutamide is a
medication used to treat prostate cancer by blocking the function of male
hormones like testosterone, which can promote the growth of cancer cells. The
oral medication bicalutamide is often used in combination with other
treatments, such as hormone therapy or surgery, for the treatment of prostate
cancer. It functions as an anti-androgen, inhibiting the harmful effects of
testosterone on cancerous cells. Off-label uses of belicutamide include
regulating women's excessive hair growth. Beclomethasone must be taken exactly
as directed by a healthcare provider due to potential side effects and drug
interactions.
A number of factors are driving the bicalutamide market worldwide. The global rise in prostate cancer cases and the progress made in cancer therapies fuel the market for this drug. Prostate cancer incidence rises with age, which increases the need for efficient treatments like bicalutamide. Proactive screening programs and increased awareness help with early detection and treatment initiation, which drives market expansion. The market reach is increased by improved healthcare access in emerging nations. Innovation is propelled by ongoing research and development initiatives targeted at improving the safety and efficacy profiles of bicalutamide. Market expansion is also greatly aided by favorable reimbursement and regulatory approval policies.Â
Market Scope
|
Report Attributes |
Description |
|
Market Size in 2024 |
USD 1.92 Billion |
|
Market Forecast in 2034 |
USD 4.52Billion |
|
CAGR % 2024-2034 |
8.11% |
|
Base Year |
2023 |
|
Historic Data |
2016-2022 |
|
Forecast Period |
2024-2034 |
|
Report USP Â |
Production, Consumption, company share, company
heatmap, company production capacity, growth factors and more |
|
Segments Covered |
By Type, By Application, by Distribution Channel, by End User and
By Region |
|
Regional Scope |
North America, Europe, APAC, South America and
Middle East and Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; France; Italy; Spain; Benelux; Nordic
Countries; Russia; China; India; Japan; South Korea; Australia; Indonesia; Thailand;
Mexico; Brazil; Argentina; Saudi Arabia; UAE; Egypt; South Africa; Nigeria |
Â
Bicalutamide Industry: Dynamics & Restrains
We Market Research: Bicalutamide Dashboard
Our marketing platform offers a comprehensive dashboard that provides clients with valuable insights into market trends over the years. Included below is a sample image of our dashboard, and specific PDF logins will be furnished to grant access to this insightful tool.
Bicalutamide Segmentation
Market- By Type Analysis
By Type, the Bicalutamide Market is Categories into Tablets, Injectable Formulations, Capsule. The Tablets segment accounts for the largest share of around 57% in 2024.
Tablets dominate the bicalutamide market
due to its price, ease of manufacturing, precision in dosage monitoring,
patient preference for oral administration, and convenience. These factors
contribute to its widespread adoption by healthcare providers and patients
undergoing prostate cancer treatment regimens.
The
following segments are part of an in-depth analysis of the global Bicalutamide
market:
|
Market Segments |
 |
|
By  Application |
·       Â
Single Drug for Prostate
Cancer ·       Â
Combined Chemotherapy For
Prostate Cancer |
|
By  Distribution
Channel |
·       Â
Hospital Pharmacies ·       Â
Retail Pharmacies ·       Â
Online Pharmacies |
|
By  End
User |
·       Â
Hospitals & Clinics ·       Â
Ambulatory Surgical Centers ·       Â
Specialty Clinics |
Â
Bicalutamide Industry: Regional Analysis
North America Market Forecast
North America dominate the Bicalutamide Market with the highest revenue generating market with share of more than 48%. North America leads the world in bicalutamide sales because to its robust healthcare system and high prostate cancer incidence. Prostate cancer screening being more well known, innovative treatment options, and favorable reimbursement policies are some of the driving forces behind the market's growth.
Europe Market Statistics
Europe is second
largest region in Bicalutamide Market. Europe also accounts for a sizable
portion of the bicalutamide market. A sizable patient base, an aging
population, and continuous research and development efforts are the main
factors driving the industry. The rise of the industry is facilitated by
government initiatives that raise awareness of cancer and provide accessibility
to healthcare.
Asia Pacific Market Forecasts
Asia Pacific is
expected to be the fastest-growing regional segment of the Bicalutamide market
during the forecast period. In the Asia Pacific region, growing healthcare
spending, a rise in prostate cancer cases, and bettering healthcare
infrastructure are driving this region's bicalutamide market's explosive
expansion. China and India, two emerging economies, are major drivers of market
expansion.
Key Market Players
The Bicalutamide
Market is dominated by a few large companies, such as
·       Â
AstraZeneca
·       Â
CORDEN PHARMA GMBH
·       Â
Zeneca GmbH
·       Â
Actavis Pharma
·       Â
Sivem Pharmaceuticals
·       Â
Sorres Pharma
·       Â
Fresenius Kabi
·       Â
ANI Pharmaceuticals
·        Accel Pharma
·         Other
1.    Â
Global
Bicalutamide Market Introduction and Market Overview
1.1.   Objectives of the Study
1.2.   Global Bicalutamide Market Scope
and Market Estimation
1.2.1. Global Bicalutamide Overall
Market Size, Revenue (US$ Mn), Market CAGR (%), Market forecast (2023 - 2034)
1.2.2. Global Bicalutamide Market
Revenue Share (%) and Growth Rate (Y-o-Y) from 2019 - 2034
1.3.   Market Segmentation
1.3.1. Component of Global Bicalutamide
Market
1.3.2. Technology of Global Bicalutamide
Market
1.3.3. Distribution Channel of Global Bicalutamide
Market
1.3.4. Region of Global Bicalutamide
Market
2.    Â
Executive Summary
2.1.   Global Bicalutamide Market Industry Trends under COVID-19 Outbreak
2.1.1. Global COVID-19 Status Overview
2.1.2. Influence of COVID-19 Outbreak
on Global Bicalutamide Market
Industry Development
2.2.   Market Dynamics
2.2.1. Drivers
2.2.2. Limitations
2.2.3. Opportunities
2.2.4. Impact Analysis of Drivers and
Restraints
2.3.   Pricing Trends Analysis &
Average Selling Prices (ASPs)
2.4.   Key Mergers & Acquisitions,
Expansions, JVs, Funding / VCs, etc.
2.5.   Porter’s Five Forces Analysis
2.5.1. Bargaining Power of Suppliers
2.5.2. Bargaining Power of Buyers
2.5.3. Threat of Substitutes
2.5.4. Threat of New Entrants
2.5.5. Competitive Rivalry
2.6.   Value Chain / Ecosystem Analysis
2.7.   Russia-Ukraine War Impacts
Analysis
2.8.   Economic Downturn Analysis
2.9.     Market Investment Opportunity
Analysis (Top Investment Pockets), By Segments & By Region
3.    Â
Global Bicalutamide Market Estimates & Historical Trend Analysis (2019 -
2023)
4.    Â
Global Bicalutamide Market Estimates & Forecast Trend Analysis, by
TYPE
4.1.   Global Bicalutamide Market
Revenue (US$ Mn) Estimates and Forecasts, by TYPE, 2019 to 2034
4.1.1. Tablets
4.1.2. Injectable Formulations
4.1.3. Capsule
5.    Â
Global Bicalutamide Market Estimates & Forecast Trend Analysis, by
Application
5.1.   Global Bicalutamide Market
Revenue (US$ Mn) Estimates and Forecasts, by Application, 2019 to 2034
5.1.1. Single Drug for Prostate Cancer
5.1.2. Combined Chemotherapy for
Prostate Cancer
6.    Â
Global Bicalutamide Market Estimates & Forecast Trend Analysis, by
Distribution Channel
6.1.   Global Bicalutamide Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel,
2019 to 2034
6.1.1. Hospital Pharmacies
6.1.2. Retail Pharmacies
6.1.3. Online Pharmacies
7.    Â
Global Bicalutamide Market Estimates & Forecast Trend Analysis, by
END USER
7.1.   Global Bicalutamide Market
Revenue (US$ Mn) Estimates and Forecasts, by Distribution Channel,
2019 to 2034
7.1.1. Hospitals & Clinics
7.1.2. Ambulatory Surgical Centers
7.1.3. Specialty Clinics
8.    Â
Global Bicalutamide Market Estimates & Forecast Trend Analysis,
by Region
8.1.   Global Bicalutamide Market
Revenue (US$ Mn) Estimates and Forecasts, by Region, 2019 to 2034
8.1.1. North America
8.1.2. Europe
8.1.3. Asia Pacific
8.1.4. Middle East & Africa
8.1.5. South America
9.    Â
North
America Bicalutamide Market: Estimates & Forecast Trend Analysis
9.1.  Â
North
America Bicalutamide Market Assessments & Key Findings
9.1.1. North America Bicalutamide
Market Introduction
9.1.2. North America Bicalutamide
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
9.1.2.1.  By TYPE
9.1.2.2.  By Application
9.1.2.3.  By Distribution
Channel
9.1.2.4.  By END USER
9.1.2.5.  By Country
9.1.2.5.1.    The U.S.
9.1.2.5.2.    Canada
9.1.2.5.3.    Mexico
10. Europe Bicalutamide
Market: Estimates & Forecast Trend
Analysis
10.1. Europe Bicalutamide Market
Assessments & Key Findings
10.1.1.  Europe Bicalutamide Market
Introduction
10.1.2.  Europe Bicalutamide Market Size
Estimates and Forecast (US$ Million) (2019 – 2034)
10.1.2.1.   By TYPE
10.1.2.2.   By Application
10.1.2.3.   By Distribution
Channel
10.1.2.4.   By END USER
10.1.2.5.   By Country
10.1.2.5.1. Germany
10.1.2.5.2. U.K.
10.1.2.5.3. France
10.1.2.5.4. Italy
10.1.2.5.5. Spain
10.1.2.5.6. Russia
10.1.2.5.7. Rest of Europe
11. Asia Pacific Bicalutamide
Market: Estimates & Forecast Trend
Analysis
11.1. Asia Pacific Market Assessments
& Key Findings
11.1.1.  Asia Pacific Bicalutamide Market
Introduction
11.1.2.  Asia Pacific Bicalutamide Market
Size Estimates and Forecast (US$ Million) (2019 – 2034)
11.1.2.1.   By TYPE
11.1.2.2.   By Application
11.1.2.3.   By Distribution
Channel
11.1.2.4.   By END USER
11.1.2.5.   By Country
11.1.2.5.1. China
11.1.2.5.2. Japan
11.1.2.5.3. India
11.1.2.5.4. Australia
11.1.2.5.5. South Korea
11.1.2.5.6. ASEAN
11.1.2.5.7. Rest of Asia Pacific
12. Middle East & Africa Bicalutamide
Market: Estimates & Forecast Trend
Analysis
12.1. Middle East & Africa Market
Assessments & Key Findings
12.1.1.  Middle
East & Africa Bicalutamide
Market Introduction
12.1.2.  Middle
East & Africa Bicalutamide
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
12.1.2.1.   By TYPE
12.1.2.2.   By Application
12.1.2.3.   By Distribution
Channel
12.1.2.4.   By END USER
12.1.2.5.   By Country
12.1.2.5.1. U.A.E.
12.1.2.5.2. Saudi Arabia
12.1.2.5.3. Egypt
12.1.2.5.4. South Africa
12.1.2.5.5. Rest of Middle East & Africa
13. South America
Bicalutamide Market: Estimates &
Forecast Trend Analysis
13.1. South America Market Assessments
& Key Findings
13.1.1.  South America Bicalutamide
Market Introduction
13.1.2.  South America Bicalutamide
Market Size Estimates and Forecast (US$ Million) (2019 – 2034)
13.1.2.1.   By TYPE
13.1.2.2.   By Application
13.1.2.3.   By Distribution
Channel
13.1.2.4.   By END USER
13.1.2.5.   By Country
13.1.2.5.1. Brazil
13.1.2.5.2. Argentina
13.1.2.5.3. Colombia
13.1.2.5.4. Rest of South America
14. Competition Landscape
14.1. Global Bicalutamide Market
Competition Matrix & Benchmarking, by Leading Players / Innovators /
Emerging Players / New Entrants
14.2. Global Bicalutamide Market
Competition White Space Analysis, By Distribution Channel
14.3. Global Bicalutamide Market
Competition Heat Map Analysis, By Distribution Channel
14.4. Global Bicalutamide Market
Concentration & Company Market Shares (%) Analysis, 2022
15. Company Profiles
15.1.                   Â
AstraZeneca
15.1.1.  Company Overview & Key Stats
15.1.2.  Financial Performance & KPIs
15.1.3.  Product Portfolio
15.1.4.  Business Strategy & Recent
Developments
* Similar details would be provided
for all the players mentioned belowÂ
15.2.     CORDEN PHARMA
GMBH
15.3.     Zeneca GmbH
15.4.     Actavis Pharma
15.5.     Sivem
Pharmaceuticals
15.6.     Sorres Pharma
15.7.     Fresenius Kabi
15.8.     ANI
Pharmaceuticals
15.9.     Accel Pharma
15.10. Others
16. Research
Methodology
16.1. External Transportations /
Databases
16.2. Internal Proprietary Database
16.3. Primary Research
16.4. Secondary Research
16.5. Assumptions
16.6. Limitations
16.7. Report FAQs
17. Research Findings & Conclusion
Quality Assurance Process
- We Market Research’s Quality Assurance program strives to deliver superior value to our clients.
We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.
Market Research Process
We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.
To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
- Project kickoff meeting with client
- Conduct frequent client communications
- Form project steering committee
- Assign a senior SR executive as QA Executive
- Conduct internal editorial & quality reviews of project deliverables
- Certify project staff in SR methodologies & standards
- Monitor client satisfaction
- Monitor realized value post-project
Case Study- Automotive Sector
One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached We Market Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).
Solution
The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research
The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.
Market Estimates and Forecast
In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.
Case Study- ICT Sector
Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.
Business Solution
An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.
Conclusion
The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2033.
Frequently Asked Questions
What is the market size of Bicalutamide Market in 2024?
Bicalutamide Market was valued at USD 1.92 Billion in 2024.
What is the growth rate for the Bicalutamide Market?
Bicalutamide Market size will increase at approximate CAGR of 8.11% during the forecasted period.
Which are the top companies operating within the market?
Major companies operating within the Bicalutamide Market Are AstraZeneca, CORDEN PHARMA GMBH, Zeneca GmbH, Actavis Pharma, Sivem Pharmaceuticals, Sorres Pharma, Fresenius Kabi, ANI Pharmaceuticals, Accel Pharma and Others.
Which region dominates the Bicalutamide Market?
North America dominates the market with an active share of 48%.
}})
Select a license type that suits your business needs
US $3750
Only Three Thousand Seven Hundred Fifty US dollar
- 1 User access
- 15% Additional Free Customization
- Free Unlimited post-sale support
- 100% Service Guarantee until achievement of ROI
US $4750
Only Four Thousand Seven Hundred Fifty US dollar
- 5 Users access
- 25% Additional Free Customization
- Access Report summaries for Free
- Guaranteed service
- Dedicated Account Manager
- Discount of 20% on next purchase
- Get personalized market brief from Lead Author
- Printing of Report permitted
- Discount of 20% on next purchase
- 100% Service Guarantee until achievement of ROI
US $5750
Only Five Thousand Seven Hundred Fifty US dollar
- Unlimited User Access
- 30% Additional Free Customization
- Exclusive Previews to latest or upcoming reports
- Discount of 30% on next purchase
- 100% Service Guarantee until achievement of ROI